Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivo Leuschner

Showing results (71-80 of 137) with videos related to

Pageof 14
Sort By:
Oncology Reports|February 22, 2008
Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in GermanyHarald Reinhard, Jennifer Reinert, Rita Beier, et al.
Pediatric Blood & Cancer|September 14, 2016
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trialsSabine Stegmaier, Ivo Leuschner, Christopher Poremba, et al.
Pediatric Blood & Cancer|March 4, 2011
Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96Guido Seitz, Tobias M Dantonello, Christoph Int-Veen, et al.
Annals of Surgical Oncology|July 9, 2016
Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P TrialGuido Seitz, Jörg Fuchs, Monika Sparber-Sauer, et al.
BMC Cancer|October 16, 2019
Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)Cristian Urla, Steven W Warmann, Monika Sparber-Sauer, et al.
Cancer|July 12, 2008
Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric OncologyBrigitte Royer-Pokora, Angela Weirich, Valerie Schumacher, et al.
Cancer|July 15, 2010
The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumorsBjörn Koos, Astrid Jeibmann, Henning Lünenbürger, et al.
Annals of Surgery|September 19, 2013
Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical studyJoerg Fuchs, Tobias M Dantonello, Gunnar Blumenstock, et al.
Oncotarget|December 15, 2016
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaJulia Dräger, Katja Simon-Keller, Tobias Pukrop, et al.
Pediatric Blood & Cancer|January 13, 2011
Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumorsVera Okpanyi, Dominik T Schneider, Susanne Zahn, et al.
Pageof 14

Showing results (71-80 of 137) with videos related to

Sort By:
Pageof 14
Oncology Reports|February 22, 2008
Rhabdoid tumors in children: prognostic factors in 70 patients diagnosed in GermanyHarald Reinhard, Jennifer Reinert, Rita Beier, et al.
Pediatric Blood & Cancer|September 14, 2016
The prognostic impact of SYT-SSX fusion type and histological grade in pediatric patients with synovial sarcoma treated according to the CWS (Cooperative Weichteilsarkom Studie) trialsSabine Stegmaier, Ivo Leuschner, Christopher Poremba, et al.
Pediatric Blood & Cancer|March 4, 2011
Treatment efficiency, outcome and surgical treatment problems in patients suffering from localized embryonal bladder/prostate rhabdomyosarcoma: a report from the Cooperative Soft Tissue Sarcoma trial CWS-96Guido Seitz, Tobias M Dantonello, Christoph Int-Veen, et al.
Annals of Surgical Oncology|July 9, 2016
Improvements in the Treatment of Patients Suffering from Bladder-Prostate Rhabdomyosarcoma: A Report from the CWS-2002P TrialGuido Seitz, Jörg Fuchs, Monika Sparber-Sauer, et al.
BMC Cancer|October 16, 2019
Treatment and outcome of the patients with rhabdomyosarcoma of the biliary tree: Experience of the Cooperative Weichteilsarkom Studiengruppe (CWS)Cristian Urla, Steven W Warmann, Monika Sparber-Sauer, et al.
Cancer|July 12, 2008
Clinical relevance of mutations in the Wilms tumor suppressor 1 gene WT1 and the cadherin-associated protein beta1 gene CTNNB1 for patients with Wilms tumors: results of long-term surveillance of 71 patients from International Society of Pediatric Oncology Study 9/Society for Pediatric OncologyBrigitte Royer-Pokora, Angela Weirich, Valerie Schumacher, et al.
Cancer|July 15, 2010
The tyrosine kinase c-Abl promotes proliferation and is expressed in atypical teratoid and malignant rhabdoid tumorsBjörn Koos, Astrid Jeibmann, Henning Lünenbürger, et al.
Annals of Surgery|September 19, 2013
Treatment and outcome of patients suffering from perineal/perianal rhabdomyosarcoma: results from the CWS trials--retrospective clinical studyJoerg Fuchs, Tobias M Dantonello, Gunnar Blumenstock, et al.
Oncotarget|December 15, 2016
LEF1 reduces tumor progression and induces myodifferentiation in a subset of rhabdomyosarcomaJulia Dräger, Katja Simon-Keller, Tobias Pukrop, et al.
Pediatric Blood & Cancer|January 13, 2011
Analysis of the adenomatous polyposis coli (APC) gene in childhood and adolescent germ cell tumorsVera Okpanyi, Dominik T Schneider, Susanne Zahn, et al.
Pageof 14